Sciecure has been devoting on the development, manufacturing, and sale for the new and generic drugs with the high quality for both the domestic and international markets.Some have been passed the inspections by CFDA.With the growing demanding, our company hasfocused to develop the overseas markets in the pharmaceutical field, a number of these products has been submittedin Europe and USA.
1. Marketing Authorization（MA）of Aripiprazole 5mg, 10mg, 15mg, and 30mg tablets are granted by UK MHRA on 30th September, 2016.
2. Marketing Authorization (MA) of Voriconazole 50mg and 200mg tablets are granted by UK MHRA on 7 October, 2016.
These are the great achievements for our company, and we will continue to develop more high quality drugs to benefit the societies.
Prev：Celebration of the International Womens Day as well as Building up our Culture
Next：Marketing Authorization (MA) of Voriconazole 50mg and 200mg tablets are granted by UK MHRA on 7 Oct